AzTrials
AzTrials

Dental CariesNCT04438252

Evaluation of Reliability of CarieScan PRO Compared With Digital Radiograph and ICDAS-II in Detection of Carious Lesions

A study testing ICDAS II, CariScan Pro and Digital Radiograpgy in people with Dental Caries, run by Cairo University at 1 site in Egypt.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The aim of this study is to evaluate the Clinical performance of alternating current impedance spectroscopy (CarieScan PRO) in comparison with digital radiograph and ICDAS-II in detection of occlusal carious lesions. Read more about this study

Who is it for?
Ages 15 to 50 yearsHealthy volunteers can take part
Conditions the study is for
Dental Caries
What is being tested?
ICDAS II, CariScan Pro and Digital Radiograpgy
Could I receive a placebo?
No, everyone receives an active treatment
How many people
166 participants
Where
1 siteEgypt
Study dates
Sep 2020to 1 Sep 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 15 to 50 years
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult

Who may be able to join

  • Posterior teeth with dark shadow on occlusal surface.
  • Vital upper or lower posterior teeth with no signs of irreversible pulpitis.
  • Intact contact with opposing teeth.
  • Teeth with no previous restorations in other surfaces.

Who cannot join

  • Periapical pathology or signs of pulpal pathology.
  • Tooth hypersensitivity.
  • Possible prosthodontic restoration of teeth.
  • Heavy occlusion and occlusal contacts or history of bruxism.
  • Severe periodontal affection.

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Faculty Of Dentistry

    Cairo, 11553

Other trials in Egypt

About this study

Official title: Evaluation of Reliability of Impedance Spectroscopy (CarieScan PRO) in Comparison With Digital Radiograph and ICDAS-II in Detection of Occlusal Carious Lesions: Diagnostic Accuracy Study.

The aim of this study is to evaluate the Clinical performance of alternating current impedance spectroscopy (CarieScan PRO) in comparison with digital radiograph and ICDAS-II in detection of occlusal carious lesions.

Read the detailed description

The visual examination is routinely used for detecting caries in dental clinics and was also used in recent studies comparing the efficacy of various visual aids. It has the benefit that it is quick and easy to perform, does not need expensive equipment, and can be completed without unnecessary radiation or fluorescence (Ismail, et al., 2007). In the current study, ICDAS-II was set as "gold standard" due to validated relationship between its codes and the histological depth of a carious lesion as in many other studies. In addition, several studies have shown good reproducibility and accuracy of ICDAS-II for caries detection in permanent teeth especially caries lesions in the outer half of the enamel (Gugnani, et al., 2010). Bitewing radiographs are used to determine the depth of caries involvement. Most often, bitewing examination is affiliated with the diagnosis of interproximal caries. It is strongly recommended that these radiographs be used in the diagnosis of occlusal caries into dentin (Pitts NB et al., 1991).

Conditions
Dental Caries
Being tested
ICDAS II, CariScan Pro, Digital Radiograpgy
Medical subject headings
Dental Caries

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • ICDAS IIDiagnostic test

    Index for caries detection

  • CariScan ProDevice

    Device for early caries detection

  • Digital RadiograpgyRadiation

    Device for digital x-ray imaging

Study groups in NCT04438252
Study groupRoleWhat they receive
Cariescan proExperimentaldevice for early caries detection
Receives: Device: CariScan Pro; Radiation: Digital Radiograpgy
ICDAS IIExperimentalIndex for caries detection
Receives: Diagnostic Test: ICDAS II

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Dental Caries

    primary occlusal caries

    Measured: slow study completion in average of 1 year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 Jun 2020
  2. Study startSep 2020 (estimated)
  3. Primary completion1 May 2021 (estimated)
  4. Study completion1 Sep 2021 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Diagnosis
Allocation
Randomised
Intervention model
Parallel groups
Masking
Quadruple blind
Who is masked
Participant, Care provider, Investigator, Outcomes assessor
Enrolment
166 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04438252
Sponsor's protocol ID
1711
Status last verified
Jun 2020
First submitted
15 Jun 2020
Last updated
18 Jun 2020
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing ICDAS II, CariScan Pro and Digital Radiograpgy in people with Dental Caries, run by Cairo University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 18 Jun 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Dental Caries (time frame: slow study completion in average of 1 year). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Jun 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in